Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aldeyra Therapeu (ALDX)

Aldeyra Therapeu (ALDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aldeyra Therapeu 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 USA

www.aldeyra.com Employees: 9 P: 781-761-4904 F: 339-674-6495

Sector:

Medical

Description:

Aldeyra Therapeutics, Inc. is a biotechnology company. The company's products target immune-mediated, inflammatory, orphan, and other diseases. It is developing NS2, a compound that binds and traps free aldehydes. Aldeyra Therapeutics, Inc. is based in Burlington, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 278,555
Enterprise Value, $K 239,055
Shares Outstanding, K 60,163
Float, K 54,387
% Float 90.40%
Short Interest, K 4,952
Short Float 8.23%
Days to Cover 3.01
Short Volume Ratio 0.45
% of Insider Shareholders 9.60%
% of Institutional Shareholders 59.71%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -55,850 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,690 K
EBIT, $ -45,180 K
EBITDA, $ -46,600 K

Growth:

1-Year Return -1.86%
3-Year Return -26.74%
5-Year Return -62.33%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 54.15%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.13 on 11/05/25
Next Earnings Date 02/27/26
Earnings Per Share ttm -0.73
EPS Growth vs. Prev Qtr 18.75%
EPS Growth vs. Prev Year 48.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ALDX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -72.25%
Return-on-Assets % -47.92%
Profit Margin % 0.00%
Debt/Equity 0.31
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.63
Book Value/Share 0.82
Interest Coverage -27.94
60-Month Beta 0.86
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar